TD Asset Management Inc Has $2.60 Million Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Key Points

• TD Asset Management Inc significantly reduced its stake in Acadia Healthcare Company by 81.8%, now holding around $2.60 million worth of shares after selling 384,600 during the quarter.
• Despite the reduction in holdings by TD Asset Management, other institutional investors such as FMR LLC and Madison Avenue Partners LP have increased their stakes in Acadia, indicating varying confidence levels among investors.
• Acadia Healthcare reported $0.40 EPS in its latest earnings, surpassing analyst expectations, and anticipates a total of 3.38 EPS for the current year, with analysts rating the stock as a "Moderate Buy."

TD Asset Management Inc cut its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 81.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 85,800 shares of the company's stock after selling 384,600 shares during the quarter. TD Asset Management Inc owned approximately 0.09% of Acadia Healthcare worth $2,601,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. FMR LLC boosted its stake in Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after acquiring an additional 4,489,681 shares during the last quarter. Madison Avenue Partners LP purchased a new position in Acadia Healthcare in the fourth quarter valued at about $76,339,000. Sachem Head Capital Management LP purchased a new position in Acadia Healthcare in the fourth quarter valued at about $52,734,000. Khrom Capital Management LLC purchased a new position in Acadia Healthcare in the fourth quarter valued at about $49,602,000. Finally, Balyasny Asset Management L.P. purchased a new position in Acadia Healthcare in the fourth quarter valued at about $43,092,000.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC opened at $21.09 on Friday. The firm's 50-day moving average price is $22.49 and its 200-day moving average price is $28.59. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.72. The company has a market cap of $1.94 billion, a PE ratio of 10.39, a PEG ratio of 4.02 and a beta of 0.88. Acadia Healthcare Company, Inc. has a 52-week low of $20.35 and a 52-week high of $82.40.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The business's quarterly revenue was up .3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.84 EPS. As a group, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on ACHC shares. Mizuho lowered their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Stephens raised shares of Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Barclays lowered their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 14th. KeyCorp lowered their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Finally, Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday. Five analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $47.94.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.